[HTML][HTML] Managing cutaneous immune-mediated diseases during the COVID-19 pandemic
T Torres, L Puig - American Journal of Clinical Dermatology, 2020 - Springer
Abstract Coronavirus disease 2019 (COVID-19) is a clinical syndrome caused by a novel
coronavirus called severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). COVID …
coronavirus called severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). COVID …
Managing Cutaneous Immune-Mediated Diseases During the COVID-19 Pandemic
T Torres, L Puig - American journal of clinical dermatology, 2020 - pubmed.ncbi.nlm.nih.gov
Coronavirus disease 2019 (COVID-19) is a clinical syndrome caused by a novel coronavirus
called severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). COVID-19 has …
called severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). COVID-19 has …
[PDF][PDF] Managing Cutaneous Immune‑Mediated Diseases During the COVID‑19 Pandemic
T Torres, L Puig - 2020 - areasaludbadajoz.com
Abstract Coronavirus disease 2019 (COVID-19) is a clinical syndrome caused by a novel
coronavirus called severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). COVID …
coronavirus called severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). COVID …
[PDF][PDF] Managing Cutaneous Immune‑Mediated Diseases During the COVID‑19 Pandemic
T Torres, L Puig - 2020 - ppgenfermagem.furg.br
Abstract Coronavirus disease 2019 (COVID-19) is a clinical syndrome caused by a novel
coronavirus called severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). COVID …
coronavirus called severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). COVID …
[引用][C] Managing Cutaneous Immune-Mediated Diseases During the COVID-19 Pandemic
T Torres, L Puig - American Journal of Clinical Dermatology, 2020 - portalrecerca.uab.cat
Managing Cutaneous Immune-Mediated Diseases During the COVID-19 Pandemic — Universitat
Autònoma de Barcelona Research Portal Skip to main navigation Skip to search Skip to main …
Autònoma de Barcelona Research Portal Skip to main navigation Skip to search Skip to main …
[引用][C] Managing Cutaneous Immune-Mediated Diseases During the COVID-19 Pandemic
T Torres, L Puig - American Journal of Clinical Dermatology, 2020 - cir.nii.ac.jp
Managing Cutaneous Immune-Mediated Diseases During the COVID-19 Pandemic | CiNii
Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 …
Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 …
[PDF][PDF] Managing Cutaneous Immune‑Mediated Diseases During the COVID‑19 Pandemic
T Torres, L Puig - 2020 - areasaludbadajoz.com
Abstract Coronavirus disease 2019 (COVID-19) is a clinical syndrome caused by a novel
coronavirus called severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). COVID …
coronavirus called severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). COVID …
Managing Cutaneous Immune-Mediated Diseases During the COVID-19 Pandemic.
T Torres, L Puig - American Journal of Clinical Dermatology, 2020 - europepmc.org
Abstract Coronavirus disease 2019 (COVID-19) is a clinical syndrome caused by a novel
coronavirus called severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). COVID …
coronavirus called severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). COVID …
[HTML][HTML] Managing Cutaneous Immune-Mediated Diseases During the COVID-19 Pandemic
T Torres, L Puig - American Journal of Clinical Dermatology, 2020 - ncbi.nlm.nih.gov
Abstract Coronavirus disease 2019 (COVID-19) is a clinical syndrome caused by a novel
coronavirus called severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). COVID …
coronavirus called severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). COVID …
[PDF][PDF] Managing Cutaneous Immune‑Mediated Diseases During the COVID‑19 Pandemic
T Torres, L Puig - 2020 - areasaludbadajoz.com
Abstract Coronavirus disease 2019 (COVID-19) is a clinical syndrome caused by a novel
coronavirus called severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). COVID …
coronavirus called severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). COVID …